[go: up one dir, main page]

BR9301136A - Oligossacarideo e formulacao farmaceutica - Google Patents

Oligossacarideo e formulacao farmaceutica

Info

Publication number
BR9301136A
BR9301136A BR9301136A BR9301136A BR9301136A BR 9301136 A BR9301136 A BR 9301136A BR 9301136 A BR9301136 A BR 9301136A BR 9301136 A BR9301136 A BR 9301136A BR 9301136 A BR9301136 A BR 9301136A
Authority
BR
Brazil
Prior art keywords
oligosaccharides
oligosacaride
pharmaceutical formulation
cell adhesion
produced
Prior art date
Application number
BR9301136A
Other languages
English (en)
Inventor
Sau-Chi Betty Yan
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BR9301136A publication Critical patent/BR9301136A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6464Protein C (3.4.21.69)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21069Protein C activated (3.4.21.69)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Amplifiers (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
BR9301136A 1992-03-12 1993-03-11 Oligossacarideo e formulacao farmaceutica BR9301136A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84986892A 1992-03-12 1992-03-12

Publications (1)

Publication Number Publication Date
BR9301136A true BR9301136A (pt) 1993-09-28

Family

ID=25306715

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9301136A BR9301136A (pt) 1992-03-12 1993-03-11 Oligossacarideo e formulacao farmaceutica

Country Status (23)

Country Link
EP (1) EP0565241B1 (pt)
JP (1) JP3171506B2 (pt)
KR (1) KR930019696A (pt)
CN (1) CN1079967A (pt)
AT (1) ATE137241T1 (pt)
AU (1) AU661762B2 (pt)
BR (1) BR9301136A (pt)
CA (1) CA2091521A1 (pt)
CY (1) CY1947A (pt)
CZ (1) CZ39093A3 (pt)
DE (1) DE69302317T2 (pt)
DK (1) DK0565241T3 (pt)
ES (1) ES2088227T3 (pt)
FI (1) FI931086L (pt)
GR (1) GR3020406T3 (pt)
HK (1) HK132396A (pt)
HU (1) HUT69613A (pt)
IL (1) IL105018A0 (pt)
MX (1) MX9301344A (pt)
NO (1) NO930890L (pt)
NZ (1) NZ247105A (pt)
YU (1) YU16993A (pt)
ZA (1) ZA931723B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1384786B1 (en) * 2001-04-02 2010-01-27 Glycomedics, Inc. Process for producing oligosaccharide chains
FI20011664L (fi) * 2001-08-17 2003-02-18 Carbion Oy Syöpäpesifiset oligoskkaridisekvenssit ja niiden käyttö
US7943763B2 (en) * 2002-07-05 2011-05-17 Otsuka Chemical Holdings Co., Ltd. Process for preparing glycopeptides having asparagine-linked oligosaccharides, and the glycopeptides
CN100378128C (zh) * 2002-12-26 2008-04-02 大塚化学株式会社 3支链型糖链天冬酰胺衍生物、该糖链天冬酰胺、该糖链和它们的制造方法
JP3884725B2 (ja) 2003-06-03 2007-02-21 三菱電機株式会社 導波管装置

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5009889A (en) * 1987-12-31 1991-04-23 Oklahoma Medical Research Foundation Treatment of dysfunctional vascular endothelium using activated protein C

Also Published As

Publication number Publication date
FI931086L (fi) 1993-09-13
DK0565241T3 (da) 1996-05-28
NZ247105A (en) 1994-11-25
KR930019696A (ko) 1993-10-18
EP0565241B1 (en) 1996-04-24
DE69302317D1 (de) 1996-05-30
ES2088227T3 (es) 1996-08-01
HU9300687D0 (en) 1993-05-28
EP0565241A1 (en) 1993-10-13
AU3519993A (en) 1993-09-16
IL105018A0 (en) 1993-07-08
MX9301344A (es) 1993-09-01
CZ39093A3 (en) 1994-03-16
ZA931723B (en) 1994-09-10
CY1947A (en) 1993-03-12
AU661762B2 (en) 1995-08-03
JP3171506B2 (ja) 2001-05-28
DE69302317T2 (de) 1996-09-19
YU16993A (sh) 1996-02-19
NO930890L (no) 1993-09-13
CA2091521A1 (en) 1993-09-13
GR3020406T3 (en) 1996-09-30
HK132396A (en) 1996-07-26
JPH0625302A (ja) 1994-02-01
ATE137241T1 (de) 1996-05-15
NO930890D0 (no) 1993-03-11
FI931086A0 (fi) 1993-03-11
HUT69613A (en) 1995-09-28
CN1079967A (zh) 1993-12-29

Similar Documents

Publication Publication Date Title
ATE72116T1 (de) Erhoehung der tetracyclinwirkung.
PT101297A (pt) Factores mitogenicos gliais, sua preparacao e utilizacao
ATE199096T1 (de) Il-11 aus säugetier
PT817847E (pt) Receptor de il-17
IT1146723B (it) Complesso antibiotico procedimento per la sua preparazione composizione farmaceutica contenente tale complesso e microorganismo per l attuazione di tale procedimento
IT1150682B (it) Procedimento per la produzione di sostanze prodotte da cellule,particolarmente di anticorpi e simili
NO930975D0 (no) Fuktighetsherdende en-komponent polysiloksanforbindelse
SE8902767L (sv) Kemiskt foerfarande
BR9301136A (pt) Oligossacarideo e formulacao farmaceutica
IT1237470B (it) Derivati di imidazolo, procedimenti per produrli e composizioni farmaceutiche che li contengono
AU3927189A (en) N-2,3-butadienyl tri- and tetraaminoalkane derivatives
FR2560212B1 (fr) Anticorps monoclonaux contre l'interferon a2 et hybridomes produisant de tels anticorps
ATE48142T1 (de) Blutprotein, verfahren zu seiner herstellung, antikoerper gegen dieses protein und dieses protein oder diese antikoerper enthaltende pharmazeutische zubereitungen.
TR199700772T1 (xx) �ubuk ba�lant�.
SE8604991D0 (sv) Snake venom growth arresting peptide
EP0723454A4 (en) Novel tripeptides useful in immune and cns therapy
IT8921024A0 (it) Procedimento per il rivestimento con pellicola di composizioni farmaceutiche con dispersioni di polimeri.
Warfel et al. Macrophage membrane glycoproteins that bind Griffonia simplicifolia I‐B4: Effect on cytotoxicity and protein secretion
Takahama et al. Role of N-acetyl-D-galactosamine residue on B151K12-derived T cell-replacing factor (B151-TRF) molecule in B cell-receptor binding and-stimulating activity.
FR2572080B1 (fr) Procede de preparation de compositions de mucopolysaccharides dotees d'une activite antithrombotique elevee, les compositions obtenues et leur application en tant que medicaments
SE8304111D0 (sv) Amino derivatives of benzylidene-pyrrolo(2,1-b)-quinazolines and benzylidene-pyrido(2,1-b)quinazolines
Wasserman et al. Further studies on the influence of interferon on pokeweed mitogen induced Ig-synthesis in vitro
IT8821370A0 (it) Perfezionamenti nella costruzione di pompe per combustibile.
IT8721455A0 (it) Composizioni farmaceutiche per la terapia di stati fisiopatologici ad accresciuto catabolismo proteico.
RU94026276A (ru) Рецепторы интерлейкина-12 и антител

Legal Events

Date Code Title Description
EE Request for examination
FC Decision: refusal
CKFC Appeal: appeal against refusal
B15K Others concerning applications: alteration of classification

Ipc: C07H 13/04 (2006.01), C12N 9/64 (2006.0